TERAWULF INC. quarterly report, Q1 FY2016

Business context and reporting period

Entity mismatch: The supplied filing is IKONICS Corporation’s Form 10-Q for the quarter ended March 31, 2016—not a TeraWulf Inc. filing. The summary below reflects the filing text provided. IKONICS reports five segments: Domestic, Export, IKONICS Imaging, Digital Texturing (DTX), and Advanced Material Solutions (AMS).

Financial performance

Amounts are in U.S. dollars; the three-month periods ended March 31 are compared.

MetricQ1 2016Q1 2015
Net sales$4.013 million$3.598 million
Gross profit / margin$1.297 million / 32.3%$1.101 million / 30.6%
Operating loss$320,306$470,766
Net loss$192,812$228,947
Basic and diluted loss per share$0.10$0.11
Operating cash flow$(155,768)$491,129
Investing cash flow$(1.031) million$(489,063)

SG&A was $1.439 million (35.9% of sales), versus $1.416 million (39.3%); R&D was $177,864 (4.4% of sales), versus $155,844 (4.3%). The income-tax benefit was $127,380, compared with $240,123.

Liquidity, capital spending, and debt

At March 31, 2016, cash and cash equivalents were $1.065 million, down from $2.248 million at December 31, 2015. Current assets were $5.965 million and current liabilities $1.179 million. The company had no borrowings on its $2.05 million asset-secured revolving line of credit at quarter-end; it expires May 31, 2017, and has no financial covenants. The filing states there was no long-term debt at quarter-end.

Capital investment was substantial: cash purchases of property, equipment, and construction in progress were $1.018 million; the balance sheet showed $3.103 million in construction in progress. The company expected approximately $1.2 million of additional 2016 capital expenditures. On April 29, 2016, after quarter-end, it obtained a $3.415 million bank term note, secured by its Morgan Park facility, at 2.14% fixed for five years before resetting, with monthly payments of $18,000 and maturity in May 2041.

Material changes and management commentary

  • Sales rose 11.5%. IKONICS Imaging increased 25.1%, attributed mainly to a new customer; AMS sales nearly doubled. Export sales grew 11.2% with stronger European and Asian demand. Domestic sales declined 1.7%, and DTX sales fell 19.4%.
  • Gross margin improved to 32.3%, reflecting improved Imaging, DTX, Export, and AMS results; Domestic margin was pressured by less favorable sales mix. Operating and net losses narrowed year over year, but the company remained unprofitable.
  • Management described AMS as growing rapidly, with long-term technology agreements with major aerospace companies in progress and further development work for military and commercial aircraft applications. A 27,300-square-foot facility expansion, estimated at $3.5 million, was expected to be completed in Q2 2016.
  • A new ERP system was expected to cost approximately $400,000 and be completed by Q3 2016. Management said current resources, operating cash generation, the credit line, and financing capacity were expected to fund operations and capital needs.
  • Foreign sales were approximately 31% of sales. Management noted that a strong U.S. dollar could make products less competitive internationally, though foreign-currency effects had not been material.

Risks, contingencies, and other items

Results are interim and may not indicate full-year performance. Management’s forward-looking statements are subject to risks and uncertainties referenced in the company’s 2015 Form 10-K and subsequent filings. The filing reports no off-balance-sheet arrangements, no legal proceedings, and no liability for unrecognized tax benefits. It identifies no material market-risk disclosure in this report. Disclosure controls were concluded to be effective, with no reported material change in internal control over financial reporting.

Investor facts to verify

  • Confirm the intended issuer: the supplied 10-Q names IKONICS Corporation, not TeraWulf Inc.
  • Check the status, final cost, and completion of the AMS building expansion and ERP implementation.
  • Assess whether AMS growth and anticipated aerospace agreements translated into sustained revenue and improved segment economics.
  • Review the April 29, 2016 term note and financing agreement, including repayment terms and the effect on liquidity and leverage.
  • Monitor operating cash generation and the company’s ability to fund planned capital spending while reporting operating losses.